학술논문

STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway
Document Type
Letter
Source
In: Leukemia and Lymphoma. (Leukemia and Lymphoma, 1 November 2016, 57(11):2681-2684)
Subject
Language
English
ISSN
10292403
10428194